Immediate Effect of Ultrasound Therapy on Bilateral Masseter Myalgia
1 other identifier
interventional
23
1 country
1
Brief Summary
This study will compare ultrasound 0.4 W/cm\^2 and 100% duty cycle versus no ultrasound (placebo) for bilateral masseter myalgia in up to 38 adult women. The dose will be applied for 5 minutes on each side. Both the dose and the starting side will be randomized. Both the subject and ultrasound operator will be blind to the dose. The outcome measures will be pressure pain threshold on both masseter muscles and both temporalis muscles, self reported pain scale (0, no pain to 10, worst pain ever), thermographic temperature of the muscles, and intraoral temperature. These outcome measures will be taken before and after each dose, so three times per subject.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2016
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2016
CompletedFirst Submitted
Initial submission to the registry
May 6, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2016
CompletedFirst Posted
Study publicly available on registry
September 8, 2016
CompletedSeptember 8, 2016
September 1, 2016
2 months
May 6, 2016
September 1, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Pressure pain threshold, change from pre- to post-ultrasound dose.
The change in pressure pain threshold from before to after the ultrasound (or placebo) will be averaged over the two masseter muscles, and over the two temporalis muscles.
Immediate. Data taken before and after each dose, so three times in the one session which lasts about one hour to completion..
Self reported pain scale, change from pre- to post-ultrasound dose which lasts about one hour to completion.
The change in self reported pain scale from before to after the ultrasound (or placebo) will be averaged over the two masseter muscles, and over the two temporalis muscles.
Immediate. Data taken before and after each dose, so three times in the one session.
Intraoral temperature
The intraoral temperature in the buccal area near the masseter muscle will be recorded before and after the ultrasound
Immediate. Data taken before and after each dose, so three times in the one session which lasts about one hour to completion.
Thermographic temperature of the muscles
The thermographic temperature of each masseter and each temporalis muscle will be recorded before and after the ultrasound.
Immediate. Data taken before and after each dose, so three times in the one session which lasts about one hour to completion.
Study Arms (2)
Ultrasound
EXPERIMENTALSubjects will receive 5 minutes of ultrasound treatment at 0.4 W/cm\^2 and 100% duty cycle on each masseter muscle.
Placebo
PLACEBO COMPARATORSubjects will receive 5 minutes of ultrasound treatment at zero power on each masseter muscle.
Interventions
Eligibility Criteria
You may qualify if:
- Adult females Bilateral myalgia based on Diagnostic Criteria for TMD (DC-TMD) (Schiffman, et al., 2014) Current pain intensity ≥4 out of 10, (where 0 is no pain and 10 is the worst pain ever) on both sides.
You may not qualify if:
- History or diagnosis of systemic musculoskeletal disorders. Rheumatologic diseases (e.g. fibromyalgia, muscular atrophy). Certain conditions such as neoplasms or fractures. Neuropathies or neurological disorders. Currently taking muscle relaxants or analgesics. Any form of physical therapy within the last 60 days.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
School of Dental Medicine
Buffalo, New York, 14214, United States
Related Publications (1)
Schiffman E, Ohrbach R, Truelove E, Look J, Anderson G, Goulet JP, List T, Svensson P, Gonzalez Y, Lobbezoo F, Michelotti A, Brooks SL, Ceusters W, Drangsholt M, Ettlin D, Gaul C, Goldberg LJ, Haythornthwaite JA, Hollender L, Jensen R, John MT, De Laat A, de Leeuw R, Maixner W, van der Meulen M, Murray GM, Nixdorf DR, Palla S, Petersson A, Pionchon P, Smith B, Visscher CM, Zakrzewska J, Dworkin SF; International RDC/TMD Consortium Network, International association for Dental Research; Orofacial Pain Special Interest Group, International Association for the Study of Pain. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Groupdagger. J Oral Facial Pain Headache. 2014 Winter;28(1):6-27. doi: 10.11607/jop.1151.
PMID: 24482784BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Willard McCall, Ph. D.
SUNY Buffalo
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 6, 2016
First Posted
September 8, 2016
Study Start
April 1, 2016
Primary Completion
June 1, 2016
Study Completion
June 1, 2016
Last Updated
September 8, 2016
Record last verified: 2016-09
Data Sharing
- IPD Sharing
- Will not share